Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sansure BiotechSHSE:688289 -2.34%67 Days Inventory is 334.92 as of Mar. 2026, which is 139% above its 10-year median of 140.11. GuruFocus rates SHSE:688289 with a GF Score™ of 67/100 and a GF Value™ of ¥20.93 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Sansure Biotech ranks worse than 84.22% on this metric.
The historical rank and industry rank for Sansure Biotech's Days Inventory or its related term are showing as below:
SHSE:688289'
s Days Inventory Range Over the Past 10 Years
Min: 49.82 Med: 140.11 Max: 466.02
Current: 371.91
During the past 9 years, Sansure Biotech's highest Days Inventory was 466.02. The lowest was 49.82. And the median was 140.11.
SHSE:688289's Days Inventory is ranked worse than 84.22% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs SHSE:688289: 371.91
Sansure Biotech's Days Inventory
increased
from Mar. 2025 (311.72) to Mar. 2026 (334.92).
It might indicate that Sansure Biotech's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sansure Biotech's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.27.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sansure Biotech's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.98.
Sansure Biotech (SHSE:688289) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sansure Biotech's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sansure Biotech's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sansure Biotech Days Inventory Related Terms
Sansure Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for Sansure Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688289 vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Sansure Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sansure Biotech Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sansure Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sansure Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sansure Biotech (SHSE:688289) has a Days Inventory of 334.92 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sansure Biotech and its competitors. This is 139% above median its historical median of 140.11. Over the past decade, Sansure Biotech's Days Inventory has ranged from 49.82 to 466.02. According to the industry distribution chart, Sansure Biotech ranks #662 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 84.2%.
Is Sansure Biotech's Days Inventory too high?
Sansure Biotech's current Days Inventory of 334.92 is 139% above median its 10-year median of 140.11. Over the past 10 years, this metric has ranged from a low of 49.82 to a high of 466.02. The Medical Devices & Instruments industry median Days Inventory is 179.60. Sansure Biotech's value of 334.92 is 86.5% above this industry median. Based on the distribution chart, Sansure Biotech ranks #662 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sansure Biotech has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sansure Biotech's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sansure Biotech ranks #662 out of 786 companies for Days Inventory. This places Sansure Biotech in the lower half of its industry. The industry median Days Inventory is 179.60. Sansure Biotech's value of 334.92 is 86.5% above this benchmark. Historically, Sansure Biotech's own Days Inventory has ranged from 49.82 to 466.02 over the past decade. While the company's 10-year median is 140.11 vs. the industry median of 179.60, Sansure Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sansure Biotech's current Days Inventory of 334.92 is 86.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sansure Biotech and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sansure Biotech's current Days Inventory is 334.92, which is 139% above median its own 10-year median of 140.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sansure Biotech stock overvalued right now?
Based on GuruFocus' analysis, Sansure Biotech (SHSE:688289) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥20.93, compared to a current price of ¥15.03 — trading 28.2% below its estimated fair value. The current Days Inventory is 334.92, which is 139% above median its 10-year median of 140.11 and 86.5% above the Medical Devices & Instruments industry median of 179.60. Sansure Biotech's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sansure Biotech (SHSE:688289), the current Days Inventory is 334.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sansure Biotech (SHSE:688289) Overvalued in 2026?
Based on GuruFocus' analysis, Sansure Biotech stock appears to be undervalued.
The current stock price of ¥15.03 is trading 28.2% below its estimated GF Value™ of ¥20.93.
GuruFocus considers Sansure Biotech to be Modestly Undervalued.
Key valuation signals for SHSE:688289:
Days Inventory: 334.92 (139% above median its 10-year median of 140.11)
GF Value™: ¥20.93 vs. price of ¥15.03 (28.2% below fair value)
Industry Position: 86.5% above the Medical Devices & Instruments median (#662 of 786)
No single metric tells the full story. See the SHSE:688289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688289 has been successfully added to your 
